Marvel Biosciences Corp (MRVL) — Tangible Net Worth Ratio
Marvel Biosciences Corp (MRVL) has a Tangible Net Worth Ratio of 100.0% as of January 2023. This metric is calculated by deducting intangible assets (CA$0.00) from net assets (CA$14.91K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See MRVL total equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Marvel Biosciences Corp Tangible Net Worth Ratio (2020–2022)
This chart shows how Marvel Biosciences Corp's Tangible Net Worth Ratio has changed across 3 annual periods from 2020 to 2022. As of January 2023, the ratio stands at 100.0%, reflecting net assets of CA$14.91K with intangible assets of CA$0.00 CAD. Also explore net asset growth rate of Marvel Biosciences Corp to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Marvel Biosciences Corp (2020–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Marvel Biosciences Corp from 2020 to 2022, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see MRVL company net worth.
| Year | Tangible NW Ratio | Net Assets (CAD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | CA$195.54K | CA$0.00 | CA$913.54K | ▲ +0.0 pp |
| 2021 | 100.0% | CA$2.36 Million | CA$0.00 | CA$2.47 Million | ▲ +0.0 pp |
| 2020 | 100.0% | CA$118.80K | CA$0.00 | CA$295.99K | — |